 |
Recombinant human granulocyte colony stimulating factor |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of implantation failure |
| USA Market Approval | USA |
| USA Designation Date | 2006-07-24 00:00:00 |
| Sponsor | Nora Therapeutics, Inc.;530 Lytton Avenue, 2nd Floor;Palo Alto, CA, 94301 |
